Psychosocial and biological factors contributing to body weight gain in schizophrenia

Online Journal of Health and Allied Sciences

Volumn 10, Issue 3, 2011, Pages

  Vella, Shae Leigh C ^a   Pai, Nagesh B ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Biological factors; Body weight gain; Obesity; Overweight; Psychosocial factors; Schizophrenia

Indexed keywords

EID: 84855186106     PISSN: None     EISSN: 09725997     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Tardieu S, Micallef J, Gentile S, Blin O Weight gain profiles of new anti-psychotics: public health consequences. Obesity Reviews. 2003;4:129-138. doi:10.1046%2Fj.1467-789X.2003.00105.x
2. Elman I, Borsook D, Lukas SE. Food intake and reward mechanisms in patients with schizophrenia: Implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology. 2006;31:2091-2120. doi:10.1038%2Fsj.npp.1301051
3. Holt RIG, Peveler RC. Obesity, serious mental illness and antipsychotic drugs. Diabetes, Obesity and Metabolism; 2009;11:665-679. doi:10.1111%2Fj.1463-1326.2009.01038.x
4. Thakore JH. Metabolic syndrome and schizophrenia. British Journal of Psychiatry. 2005;186(6):455-456. doi:10.1192%2Fbjp.186.6.455
5. Deng C, Weston-Green K, Huang X. The role of histaminergic H1 and H3 in food intake: A mechanism for atypical antipsychotic-induced weight gain? Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2010;34:1-4. doi:10.1016%2Fj.pnpbp.2009.11.009
6. Alvarez-Jimenez M, Gonzalez-Blanch C, Crespo-Facorro B, Hetrick S, Rodriguez-Sanchez JM, Perez-Iglesias R, Vazquez-Barquero JL. Antipsychotic-induced weight gain in chronic and first episode psychotic disorders: A systematic critical reappraisal. CNS Drugs. 2008;22(7):547-562.
7. Levine JA, Schleusner SJ, Jensen MD. Energy expenditure and non-exercise activity. The American Journal of Clinical Nutrition. 2000;72:1451-1454.
8. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: What mental health professionals need to know. American Journal of Psychiatry. 2000;157(6):854-866. doi:10.1176%2Fappi.ajp.157.6.854
9. Kirkbride JB, Barker D, Cowden F, Stamps R, Yang M, Jones PB, Coid JW. Psychoses, ethnicity and socio-economic status. British Journal of Psychiatry. 2008;193:18-24. doi:10.1192%2Fbjp.bp.107.041566
10. Peet M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices. British Journal of Psychiatry. 2004;184(5):404-408. doi:10.1192%2Fbjp.184.5.404
11. Girgis RR, Javitch JA, Lieberman JA. Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signalling pathway. Molecular Psychiatry 2008;13:918-929. doi:10.1038%2Fmp.2008.40
12. Venkatasubramanian G, Chittiprol S, Neelakantachar N, Shetty T, Gangadhar BN. Effects of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: A longitudinal study. Schizophrenia Research. 2010;119:131-137. doi:10.1016%2Fj.schres.2010.01.033
13. Venkatasubramanian G, Chittiprol S, Neelakantachar N, Magadi N, Naveen MD, Thirthall J, Bangalore N, Gangadhar BN, Shetty T. Insulin and insulin-like growth factor-1 abnormalities in anti-psychotic-naive schizophrenia. The American Journal of Psychiatry. 2007;164:1557-1560. doi:10.1176%2Fappi.ajp.2007.07020233
14. Volkow ND, Wang G, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends in Cognitive Sciences. 2011;15(1):37-45. doi:10.1016%2Fj.tics.2010.11.001
15. Volkow ND, Wang G, Fowler JS, Tomasi D, Telang F. Addiction: Beyond dopamine reward circuitry. PNAS September 13, 2011;108(37):15037-15042. doi: 10.1073/pnas.1010654108. Available at http://www.pnas.org/content/108/37/15037.full
16. Tarricone I, Gozzi BF, Serretti A, Grieco D, Berardi D. Weight gain in antipsychotic-naive patients: a review and meta-analysis. Psychological Medicine. 2010;40:187-200. doi:10.1017%2FS0033291709990407